Reckitt Benckiser Group plc (LON:RKT – Get Free Report) has been assigned an average rating of “Hold” from the seven analysts that are presently covering the firm, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is GBX 6,204.29.
RKT has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Reckitt Benckiser Group from GBX 5,460 to GBX 5,430 and set a “hold” rating for the company in a research note on Tuesday, April 28th. Berenberg Bank reduced their target price on shares of Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating for the company in a research note on Friday, April 24th. Royal Bank Of Canada reiterated a “neutral” rating and issued a GBX 6,200 target price on shares of Reckitt Benckiser Group in a research note on Friday, May 15th. Citigroup reduced their target price on shares of Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating for the company in a research note on Thursday, April 23rd. Finally, Jefferies Financial Group reiterated a “hold” rating and issued a GBX 5,600 target price on shares of Reckitt Benckiser Group in a research note on Tuesday, June 16th.
Read Our Latest Stock Report on RKT
Reckitt Benckiser Group Stock Performance
Insider Transactions at Reckitt Benckiser Group
In other news, insider Shannon Eisenhardt bought 432 shares of Reckitt Benckiser Group stock in a transaction dated Friday, June 12th. The stock was purchased at an average price of £432 per share, for a total transaction of £186,624. Also, insider Marybeth Hays bought 340 shares of Reckitt Benckiser Group stock in a transaction dated Monday, June 1st. The stock was purchased at an average price of GBX 4,585 per share, with a total value of £15,589. Company insiders own 0.45% of the company’s stock.
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Further Reading
- Five stocks we like better than Reckitt Benckiser Group
- 3 Retail Winners Using Cash Flow to Stay Ahead
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
